Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT

被引：90

作者：

Schmid, Christoph ^{[1
]}

Labopin, Myriam ^{[2
,3
]}

Schaap, Nicolaas ^{[4
]}

Veelken, Hendrik ^{[5
]}

Schleuning, Michael ^{[6
]}

Stadler, Michael ^{[7
]}

Finke, Juergen ^{[8
]}

Hurst, Erin ^{[9
]}

Baron, Frederic ^{[10
]}

Ringden, Olle ^{[11
]}

Bug, Gesine ^{[12
]}

Blaise, Didier ^{[13
]}

Tischer, Johanna ^{[14
]}

Bloor, Adrian ^{[15
]}

Esteve, Jordi ^{[16
]}

Giebel, Sebastian ^{[17
,18
]}

Savani, Bipin ^{[19
]}

Gorin, Norbert-Claude ^{[2
,3
]}

Ciceri, Fabio ^{[20
]}

Mohty, Mohamad ^{[2
,3
]}

Nagler, Anton ^{[21
]}

机构：

[1] Univ Munich, Dept Haematol & Oncol, Klinikum Augsburg, Stenglinstr 2, D-86156 Augsburg, Germany

[2] Univ Paris 06, Paris, France

[3] EBMT Data Off, Paris, France

[4] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[5] Leiden Univ Hosp, BMT Ctr Leiden, Leiden, Netherlands

[6] Deutsch Klin Diagnost, KMT Zentrum, Wiesbaden, Germany

[7] Hannover Med Sch, Dept Haematol & Oncol, Hannover, Germany

[8] Univ Freiburg, Dept Med Haematol & Oncol, Freiburg, Germany

[9] NCCN Freeman Hosp, Bone Marrow Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England

[10] Univ Liege, Dept Med, Div Haematol, Liege, Belgium

[11] Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Therapeut Immunol, Karolinska Inst, Stockholm, Sweden

[12] Univ Klinikum, Dept Med 2, Haematol & Oncol, Frankfurt, Germany

[13] Marseille Inst Paoli Calmettes, Programme Transplantat & Therapie, Cellulaire Ctr Rech Cancerol, Marseille, France

[14] Ludwig Maximilians Univ Munchen, Dept Med 3, Haematol & Oncol, Munich, Germany

[15] Christie NHS Fdn Trust, Stein Cell Transplantat Unit, Manchester, Lancs, England

[16] Hosp Clin Barcelona, IDIBAPS, Dept Haematol, Barcelona, Spain

[17] Maria Sklodowska Curie Canc Ctr, Gliwice, Poland

[18] Inst Oncol, Gliwice Branch, Gliwice, Poland

[19] Vanderbilt Univ Sch Med, Long Term Transplant Clin, Nashville, TN USA

[20] Univ Milan, Dept Haematol, Osp San Raffaele, Milan, Italy

[21] Chaim Sheba Med Ctr, Tel Hashomer, Israel

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 184卷 / 05期

关键词：

acute leukaemia; allogeneic stem cell transplantation; DLI; relapse prevention; ACUTE MYELOID-LEUKEMIA; STAGE ACUTE-LEUKEMIA; SURVIVAL; PREVENTION; ANTIGEN;

D O I：

10.1111/bjh.15691

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Strategies for relapse prevention after allogeneic transplantation in acute leukaemia are warranted. A registry-based matched-pair analysis evaluated the efficacy of prophylactic donor lymphocyte infusion (proDLI). Adults receiving proDLI in complete remission (CR) and controls were pair-matched for age, diagnosis, cytogenetics, stage, donor, gender, conditioning and T-cell depletion. Eighty-nine pairs were identified (median follow-up: 6.9 years). Within the entire cohort, no difference was observed. However, among patients with high-risk acute myeloid leukaemia (AML) (unfavourable cytogenetics and/or transplanted beyond first CR), proDLI recipients had improved overall survival (69.8% vs. 40.2% in controls, P = 0.027). ProDLI has moderate efficacy, but can contribute to improved outcome in high-risk AML.

引用

页码：782 / 787

页数：6

共 50 条

[31] Haploidentical stem cell transplantation for children with acute leukaemia
Marks, DI
Khattry, N
Cummins, M
Goulden, N
Green, A
Harvey, J
Hunt, LP
Keen, L
Robinson, SP
Steward, CG
Cornish, JM
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (02) : 196 - 201
[32] Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation
Boehm, A.
Sperr, W. R.
Leitner, G.
Worel, N.
Oehler, L.
Jaeger, E.
Mitterbauer, M.
Haas, O. A.
Valent, P.
Kalhs, P.
Rabitsch, W.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (12) : 945 - 952
[33] Acute myeloid leukaemia relapse after allogeneic haematopoietic stem cell transplantation: Mechanistic diversity and therapeutic directions
Herrity, Elizabeth
Pereira, Mariana Pinto
Kim, Dennis Dong Hwan
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (05) : 722 - 735
[34] Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response
Dietz, Andrew C.
DeFor, Todd E.
Brunstein, Claudio G.
Wagner, John E., Jr.
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (02) : 209 - 212
[35] Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT
Christopeit, Maximilian
Labopin, Myriam
Gorin, Norbert-Claude
Saraceni, Francesco
Passweg, Jakob
Forcade, Edouard
Maertens, Johan
Van Lint, Maria Teresa
Bosi, Alberto
Niederwieser, Dietger
Ehninger, Gerhard
Polge, Emmanuelle
Mohty, Mohamad
Nagler, Arnon
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1532 - 1542
[36] Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
de Witte, T
Hermans, J
Vossen, J
Bacigalupo, A
Meloni, G
Jacobsen, N
Ruutu, T
Ljungman, P
Gratwohl, A
Runde, V
Niederwieser, D
van Biezen, A
Devergie, A
Cornelissen, J
Jouet, JP
Arnold, R
Apperley, J
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) : 620 - 630
[37] Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis
Yang, Luxin
Tan, Yamin
Shi, Jimin
Zhao, Yanmin
Yu, Jian
Hu, Yongxian
Lai, Xiaoyu
Yang, Yang
Huang, He
Luo, Yi
BONE MARROW TRANSPLANTATION, 2021, 56 (03) : 664 - 672
[38] Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT
Battipaglia, G.
Labopin, M.
Candoni, A.
Fanin, R.
El Cheikh, J.
Blaise, D.
Michallet, M.
Ruggeri, A.
Contentin, N.
Ribera, J. M.
Stadler, M.
Sierra, J.
Borne, P. A. von Dem
Bloor, A.
Socie, G.
Nagler, A.
Mohty, M.
BONE MARROW TRANSPLANTATION, 2017, 52 (04) : 592 - 599
[39] Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Canaani, Jonathan
Labopin, Myriam
Huang, Xiao J.
Ciceri, Fabio
Van Lint, Maria T.
Bruno, Benedetto
Santarone, Stella
Diez-Martin, Jose L.
Blaise, Didier
Chiusolo, Patrizia
Wu, Depei
Mohty, Mohamad
Nagler, Arnon
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (03) : 411 - 420
[40] The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience
Loke, Justin
Malladi, Ram
Moss, Paul
Craddock, Charles
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (01) : 129 - 146

← 1 2 3 4 5 →